Evidence map›Paper›PMID 32859701›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

First-in-Human Evaluation of

Mika Naganawa, Songye Li, Nabeel Nabulsi, Shannan Henry, Ming-Qiang Zheng, Richard Pracitto, Zhengxin Cai, Hong Gao, Michael Kapinos, David Labaree and 3 more

2 registry-linked trialsOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 95 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05360082 narecruitingnot on this mapstarted 2024, after this paper: background citation

Direct Quantitative Comparison Between [11C]UCB-J and [18F]SynVest-1 PET as Markers for Synaptic Density in Huntington's Disease.

TypeinterventionalSponsorUniversitaire Ziekenhuizen KU LeuvenRan2024 to 2026Enrolled35ConditionsHuntington DiseaseArms[11C]UCB-J PET, [18F]SynVest-1 PET
NCT06445582 unknown statusnot on this mapstarted 2024, after this paper: background citation

Synaptic Vesicle Glycoprotein 2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration

TypeobservationalSponsorAnhui Provincial HospitalRan2024 to 2025Enrolled80ConditionsAlzheimer DiseaseArms[18F]SDM-8
3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Imaging Synaptic Vesicle Protein SV2C withACS chemical neuroscience · 2026
    Article
  7. Assessment of noninvasive quantification of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  8. Review
  9. "Pseudo-reference-based Input Function Shape" (pRef-IFS): Towards a True image-derived input function for PET kinetic modeling.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  10. Exploring synaptic density patterns in cerebral small vessel disease: insights from [European journal of nuclear medicine and molecular imaging · 2026
    Article
  11. Noninvasive Quantification of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  12. SV2A PET Imaging Detects Severity-Dependent Synaptic Changes After Experimental Traumatic Spinal Cord Injury.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison ofAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  17. Article
  18. SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  19. Article
  20. Direct evidence for synaptic density changes in tinnitus:European journal of nuclear medicine and molecular imaging · 2026
    Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mika NaganawaYale University PET Center, New Haven, Connecticut mika.naganawa@yale.edu henry.huang@yale.edu.
Songye LiYale University PET Center, New Haven, Connecticut.
Nabeel NabulsiYale University PET Center, New Haven, Connecticut.
Shannan HenryYale University PET Center, New Haven, Connecticut.
Ming-Qiang ZhengYale University PET Center, New Haven, Connecticut.
Richard PracittoYale University PET Center, New Haven, Connecticut.
Zhengxin CaiYale University PET Center, New Haven, Connecticut.
Hong GaoYale University PET Center, New Haven, Connecticut.
Michael KapinosYale University PET Center, New Haven, Connecticut.
David LabareeYale University PET Center, New Haven, Connecticut.
David MatuskeyYale University PET Center, New Haven, Connecticut.
Yiyun HuangYale University PET Center, New Haven, Connecticut.
Richard E CarsonYale University PET Center, New Haven, Connecticut.
Yale University · USYale Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER, CHRISTOPHER H VAN DYCK · 2020 to 2026
$30.2M
Validation of Fluorine-18 radioligand for PET imaging of synaptic density in Alzheimer's diseaseR01AG065474 · NIA · YALE UNIVERSITY · PI HUANG, YIYUN HENRY, VAN DYCK, CHRISTOPHER H · 2020 to 2024
$3.9M
SV2A PET in Spinal Cord Injury ImagingR01NS123183 · NINDS · YALE UNIVERSITY · PI Zhengxin Cai · 2022 to 2026
$3.3M
PET Imaging of Synaptic Density in Alzheimers DiseaseR01AG052560 · NIA · YALE UNIVERSITY · PI CARSON, RICHARD E., VAN DYCK, CHRISTOPHER H · 2017 to 2020
$3.2M
NCATS NIH HHS UL1 TR001863NCRR NIH HHS UL1 RR024139NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG052560NIA NIH HHS R01 AG065474NINDS NIH HHS R01 NS123183
6 · The paper itself

Abstract

The use of synaptic vesicle glycoprotein 2A radiotracers with PET imaging could provide a way to measure synaptic density quantitatively in living humans.

Indexed as

AdultFemaleGPI-Linked ProteinsHealthy VolunteersHumansLigandsMalePositron-Emission TomographyPyridinesPyrrolidinonesSafetySynaptic Vesicles1-((3-(methylpyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-oneGP2 protein, humanGPI-Linked ProteinsLigandsPyridinesPyrrolidinonesbrain imagingkinetic modelingPETSV2Asynaptic density

Identifiers

PMID32859701
PMCPMC8049363
OpenAlexW3082957830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.